Status:
UNKNOWN
Sustaining Remission From PTSD Using Tuned Vibroacoustic Stimulation (TVS) Following MDMA-Assisted Psychotherapy
Lead Sponsor:
Apollo Neuroscience, Inc.
Collaborating Sponsors:
The Board of Medicine
Conditions:
Stress Disorders, Post-Traumatic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research is to examine a wearable device called Apollo that emits gentle vibrations found to benefit mood, energy, and focus. We want to understand how it affects outcomes related ...
Detailed Description
The study examines the effect of the Apollo wearable on its users after undergoing MDMA-assisted psychotherapy. There will be no study specific modification to the MDMA-assisted psychotherapy that par...
Eligibility Criteria
Inclusion
- Age 18 or over
- Completion of the MAPS MDMA-Assisted Psychotherapy for PTSD clinical trial (treatment cohort)
- completion of the MAPS MDMA-Assisted Psychotherapy for PTSD clinical trial (placebo cohort)
- enrolled in the MAPS MDMA-Assisted Psychotherapy for PTSD clinical trial, but dropped out
Exclusion
- Unable to give adequate informed consent
- Have any current problem which, in the opinion of the investigator might interfere with participation
- Are unable to complete questionnaires written in English
Key Trial Info
Start Date :
December 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05274230
Start Date
December 8 2021
End Date
December 31 2025
Last Update
February 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Apollo Neuroscience, Inc.
Pittsburgh, Pennsylvania, United States, 15219